Preliminary studies show conolidine could inhibit certain ion channels, decreasing neuronal excitability and restricting ache signals. This mechanism is especially applicable in neuropathic suffering, the place abnormal signaling results in persistent soreness. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to agony notion. https://neilq257lfx2.wikigop.com/user